Chandelier
Senior Member (Voting Rights)
Harriet Carroll got her comment published:
Harriet Carroll: Long Covid Scientific Consultancy
@angryhacademic.bsky.social
Delighted to say my comment got published! There was a lot of critiques I considered about this study, but the problem is that if we critique an individual study, future studies can just avoid that particular critique. So I tried to take a different approach
In this case, it is clear in Berry's study someone mentioned PEM, so they "addressed" it (badly, but they can still say they provided info and support).
They addressed a critique we've been repeating for years. In their mind: Job done
So instead of highlighting the problems with this particular study, I wanted to highlight that doing these kind of studies is BY DEFAULT unethical. Full stop.
There is no doing this the "right" way.
This study in isolation is not the problem per se, but rather the entire academic system that repeatedly allows these studies to go ahead is:
Non-experts deciding they can and should run studies like this
Funders not having appropriate expertise, & funding these studies
Ethics boards being duped by academics who can justify any idea they want to do
Patients having inadequate support and education from their medical teams to understand why they should not participate in these kinds of studies
Doing a study against current and established guidelines should not happen bar in very exceptional, highly-specialised, circumstances, led by a legitimate team of experts. And I think this is something we really need to hammer home
Anyway, I hope my point comes across clear and is a useful addition for this and future study critiques
November 18, 2025
Ethics of doing research against established clinical guidelines
Harriet Carroll, PhD | Lund University
I read with interest the study by Berry et al., investigating the effect of resistance exercise in patients with post-COVID-19 sequelae. However, this research raises wider ethical issues that are pervasive in long COVID research.
Post-COVID-19 sequelae encompasses several, potentially co-occurring, subtypes: deconditioning particularly in the context of hospitalisation; direct organ damage; new-onset diagnosable disease(s); and/or new-onset currently unknown disease(s)/pathology(ies). Individual symptoms may overlap across groups but have different underlying pathophysiology; for example, fatigue could be caused by autoimmunity, hypercoagulability, lung damage, nervous system damage, etc. Conducting trials—even for rehabilitation—as if these were a homogenous group with unified needs is somewhat akin to grouping multiple sclerosis, Parkinson’s, and dysautonomia patients together because they all suffer with fatigue, sensorimotor impairments, and cognitive dysfunction, and is therefore unhelpful.
Berry et al., were aware of risks associated with exercise in some long COVID patients via discussion of post-exertional malaise (PEM) in both the participant information sheet (PIS) and manuscript. If assessed properly, PEM is the cardinal symptom of myalgic encephalomyelitis (ME),[1] and in worst cases can cause permanent worsening. Accordingly, exercise—including under the premise of deconditioning—is contraindicated in ME, and NICE guidelines state any exercise programme should only be done under a ME specialist team.[2] There are no ME specialists in NHS Scotland nor the study team, as confirmed by personal correspondence with NHS Greater Glasgow & Clyde, e.g. stating pulmonary rehabilitation physiotherapists were consulted. None of these points were explained in the PIS, nor were risks pertaining to other known pathophysiology commonly found in long COVID.[3] Therefore, by proxy, this trial contravened clinical guidelines which raises serious ethical issues—a problem that is unfortunately not unique to this study.
Further, studies focused on rehabilitation without treating ongoing underlying pathology are generally unhelpful, just as it would be unethical to rehabilitate stroke patients without first treating the stroke. Post-hospitalisation rehabilitation in recovered but deconditioned patients is well-established, again raising ethical questions regarding the purpose of studies like that conducted by Berry et al.
Regardless of study findings, it does not seem ethical to go against established clinical guidelines, particularly without specialist involvement/oversight. This also highlights problems with how studies are ethically reviewed as disease specialists are not necessarily present. Considering the overall lack of funding for diseases like ME and long COVID, it is imperative any grants are used for ethically sound, pathology-targeted, and clinically useful research.
References
1. Davenport TE, Chu L, Stevens SR, Stevens J, Snell CR, Van Ness JM. Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Work. 2023;74(5):1199-1213. doi:10.3233/WOR-220554.
2. National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. https://www.nice.org.uk/guidance/ng206. Accessed November 16, 2025.
3. Carroll HA, Harvey N. Letter to the Editor RE: Exercise is the Most Important Medicine for COVID-19. Curr Sports Med Rep. 2023;22(12);423. doi:10.1249/JSR.0000000000001123.
CONFLICT OF INTEREST: HAC runs the Long Covid Scientific Consultancy, providing education, advocacy, and resources on long COVID and related diseases.
Ethics of doing research against established clinical guidelines
Harriet Carroll, PhD | Lund University
I read with interest the study by Berry et al., investigating the effect of resistance exercise in patients with post-COVID-19 sequelae. However, this research raises wider ethical issues that are pervasive in long COVID research.
Post-COVID-19 sequelae encompasses several, potentially co-occurring, subtypes: deconditioning particularly in the context of hospitalisation; direct organ damage; new-onset diagnosable disease(s); and/or new-onset currently unknown disease(s)/pathology(ies). Individual symptoms may overlap across groups but have different underlying pathophysiology; for example, fatigue could be caused by autoimmunity, hypercoagulability, lung damage, nervous system damage, etc. Conducting trials—even for rehabilitation—as if these were a homogenous group with unified needs is somewhat akin to grouping multiple sclerosis, Parkinson’s, and dysautonomia patients together because they all suffer with fatigue, sensorimotor impairments, and cognitive dysfunction, and is therefore unhelpful.
Berry et al., were aware of risks associated with exercise in some long COVID patients via discussion of post-exertional malaise (PEM) in both the participant information sheet (PIS) and manuscript. If assessed properly, PEM is the cardinal symptom of myalgic encephalomyelitis (ME),[1] and in worst cases can cause permanent worsening. Accordingly, exercise—including under the premise of deconditioning—is contraindicated in ME, and NICE guidelines state any exercise programme should only be done under a ME specialist team.[2] There are no ME specialists in NHS Scotland nor the study team, as confirmed by personal correspondence with NHS Greater Glasgow & Clyde, e.g. stating pulmonary rehabilitation physiotherapists were consulted. None of these points were explained in the PIS, nor were risks pertaining to other known pathophysiology commonly found in long COVID.[3] Therefore, by proxy, this trial contravened clinical guidelines which raises serious ethical issues—a problem that is unfortunately not unique to this study.
Further, studies focused on rehabilitation without treating ongoing underlying pathology are generally unhelpful, just as it would be unethical to rehabilitate stroke patients without first treating the stroke. Post-hospitalisation rehabilitation in recovered but deconditioned patients is well-established, again raising ethical questions regarding the purpose of studies like that conducted by Berry et al.
Regardless of study findings, it does not seem ethical to go against established clinical guidelines, particularly without specialist involvement/oversight. This also highlights problems with how studies are ethically reviewed as disease specialists are not necessarily present. Considering the overall lack of funding for diseases like ME and long COVID, it is imperative any grants are used for ethically sound, pathology-targeted, and clinically useful research.
References
1. Davenport TE, Chu L, Stevens SR, Stevens J, Snell CR, Van Ness JM. Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Work. 2023;74(5):1199-1213. doi:10.3233/WOR-220554.
2. National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. https://www.nice.org.uk/guidance/ng206. Accessed November 16, 2025.
3. Carroll HA, Harvey N. Letter to the Editor RE: Exercise is the Most Important Medicine for COVID-19. Curr Sports Med Rep. 2023;22(12);423. doi:10.1249/JSR.0000000000001123.
CONFLICT OF INTEREST: HAC runs the Long Covid Scientific Consultancy, providing education, advocacy, and resources on long COVID and related diseases.